Yahoo
NYSE - Delayed Quote USD

Dr. Reddy's Laboratories Limited (RDY)

14.17 +0.06 (+0.43%)
At close: October 30 at 4:00:02 PM EDT
14.17 0.00 (0.00%)
After hours: October 30 at 5:21:51 PM EDT
Trade RDY on Coinbase
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
329,843,000
335,933,000
325,535,000
279,164,000
245,879,000
Cost of Revenue
166,602,000
158,669,000
135,107,000
115,557,000
106,536,000
Gross Profit
163,241,000
177,264,000
190,428,000
163,607,000
139,343,000
Operating Expense
131,895,000
127,141,000
118,414,000
98,299,000
80,289,000
Operating Income
31,346,000
50,123,000
72,014,000
65,308,000
59,054,000
Net Non Operating Interest Income Expense
1,090,000
-12,000
-152,000
567,000
-248,000
Other Income Expense
2,787,000
4,706,000
4,922,000
5,995,000
1,561,000
Pretax Income
35,223,000
54,817,000
76,784,000
71,870,000
60,367,000
Tax Provision
7,639,000
12,351,000
19,539,000
16,186,000
15,300,000
Net Income Common Stockholders
27,986,000
42,850,000
56,544,000
55,684,000
45,067,000
Diluted NI Available to Com Stockholders
27,986,000
42,850,000
56,544,000
55,684,000
45,067,000
Basic EPS
33.61
51.48
67.88
66.93
54.28
Diluted EPS
33.58
51.42
67.78
66.80
54.17
Basic Average Shares
832,738.19
832,440.59
832,950.41
831,968.52
830,174.45
Diluted Average Shares
833,397.03
833,331.69
834,179.13
833,537.68
831,940.85
Total Operating Income as Reported
32,030,000
50,551,000
71,843,000
67,729,000
57,144,000
Total Expenses
298,497,000
285,810,000
253,521,000
213,856,000
186,825,000
Net Income from Continuing & Discontinued Operation
27,986,000
42,850,000
56,544,000
55,684,000
45,067,000
Normalized Income
25,803,431.56
39,329,560
53,015,250
51,181,040
44,173,750
Interest Income
5,594,000
3,726,000
2,677,000
2,278,000
1,180,000
Interest Expense
4,504,000
3,738,000
2,829,000
1,711,000
1,428,000
Net Interest Income
1,090,000
-12,000
-152,000
567,000
-248,000
EBIT
39,727,000
58,555,000
79,613,000
73,581,000
61,795,000
EBITDA
61,157,000
79,160,000
96,671,000
88,422,000
74,431,000
Reconciled Cost of Revenue
166,602,000
158,669,000
135,107,000
115,557,000
106,536,000
Reconciled Depreciation
21,430,000
20,605,000
17,058,000
14,841,000
12,636,000
Net Income from Continuing Operation Net Minority Interest
27,986,000
42,850,000
56,544,000
55,684,000
45,067,000
Total Unusual Items Excluding Goodwill
2,787,000
4,572,000
4,705,000
5,848,000
1,191,000
Total Unusual Items
2,787,000
4,572,000
4,705,000
5,848,000
1,191,000
Normalized EBITDA
58,370,000
74,588,000
91,966,000
82,574,000
73,240,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
604,431.56
1,051,560
1,176,250
1,345,040
297,750
3/31/2023 - 4/11/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: